A fascinating conversation between Candesic Senior Partner Dr Michelle Tempest and Jocelyn Ormond, Partner at Ashfords LLP, on AI regulation in healthcare. Listen as they discuss the exciting world of AI drug discovery, AI surveillance and monitoring algorithms in the real world. They examine the lessons that can be learned about gaining patient data consent from the ophthalmology collaboration between Moorfields Eye Hospital, London and Google DeepMind. To listen, follow the link below https://lnkd.in/dP2nxPfM Insilico Medicine Newton's Tree #AI #drugdiscovery #therapeutics #healthcareinvestors #podcast #investment #innovation #AISurveillance #AIinhealthcare #dataconsent
Candesic’s Post
More Relevant Posts
-
In current scenario, Healthcare is the biggest sector for the AI applications. With new developments including Generative AI and Large Language Models, we are going to see revolutionary transformations in Healthcare and Medical industry in next few years. We as humans need precise and fast results in drug discovery, diagnosis process, healing time, surgery results, pre-disease symptoms, predictive healthcare, community infection threats, and readiness with next epidemics and pandemics. Here is an overview of a few of the high potential areas in healthcare. I will post more details in upcoming articles. Rahul Rathore #ai #healthcare #genai #generativeai #artificialintelligence #appliedmedicine #doctors #hospital #management #technology
To view or add a comment, sign in
-
#AITechnology is crucial for tackling challenges in healthcare, such as complex disease diagnoses, unequal resource distribution, and personalized care. By integrating AI with medical big data and deep learning, it enables in-depth analysis of large volumes of medical imaging data. The Pilot-c and Taikon Series are applied full-process AI HD Image Chain. For example, in #cardiovascularimaging, the system can precisely assess coronary artery stenosis and locate plaques, offering accurate, quantitative diagnostic recommendations, which improves both accuracy and efficiency. For details: Web: www.wemedmedical.com E-mail: internationalsales@we-med.com #HealthCare #MedicalImaging #CardioIntervention #NeuroIntervention
To view or add a comment, sign in
-
-
🌟 Fantastic Work by Modella AI! 🌟 Huge congratulations to the team at Modella AI for achieving FDA Breakthrough Device Designation for their generative AI co-pilot, PathChat DX! 🎉 This recognition highlights the potential of PathChat DX to improve diagnostic workflows in pathology. It combines generative AI, multimodal analysis, and pathology foundation models to assist pathologists in making accurate, timely diagnoses. With growing demands and challenges in the pathology field, innovations like PathChat DX could help reduce diagnostic variability, improving efficiency, and ultimately enhancing patient outcomes. 🔎 Important to note: While the Breakthrough Device Designation is a significant milestone, it does not imply FDA clearance or approval. PathChat DX is still undergoing further testing and evaluation to meet regulatory standards and clinical safety requirements. 👏 Hats off to the Modella AI team for pushing the boundaries of what generative AI can achieve in healthcare! https://lnkd.in/dDHB2BkH #GenerativeAI #HealthcareInnovation #Pathology #AIinHealthcare #FDA #BreakthroughDeviceDesignation
To view or add a comment, sign in
-
𝐎𝐰𝐤𝐢𝐧 𝐮𝐧𝐯𝐞𝐢𝐥𝐬 𝐧𝐞𝐰 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐨𝐫 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐩𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐀𝐈 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 Owkin, a leader in AI-driven healthcare, revolutionizes digital pathology solutions. The company introduces groundbreaking AI tools to advance medical research efficiency. These innovations aim to improve diagnostic accuracy and patient outcomes globally. Owkin combines AI and pathology to uncover hidden patterns in complex data. Their cutting-edge algorithms enhance disease detection and accelerate drug discovery. By leveraging federated learning, Owkin ensures privacy while training robust AI models. Collaboration with top healthcare institutions drives progress in personalized medicine. Owkin empowers researchers to develop tailored treatments with greater precision. This marks a pivotal step toward integrating AI in modern healthcare systems. Their efforts emphasize the potential of AI in addressing critical medical challenges. #HealthcareInnovation #DigitalPathology #ArtificialIntelligence #AIHealthcare #MedicalResearch #AI
To view or add a comment, sign in
-
-
🚀 New Blog Post Alert! 🚀 How will the AI Act shape the future of digital pathology solutions that rely on AI? In our latest blog post, we explore the potential consequences and opportunities this legislation brings to the field. 👉 Read the full post here: https://lnkd.in/dVuBYChW #AIAct #DigitalPathology #AIInHealthcare #RegulatoryAffairs
To view or add a comment, sign in
-
-
Dr. Anthony Law discusses the potential of using voice as a non-invasive biomarker for detecting diseases through AI and deep learning, envisioning future scenarios where patients can receive health assessments via kiosks or voice-activated assistants, ultimately providing more tools for individuals to engage with their healthcare. Check out the full episode: https://ow.ly/PrXV50TrZvb #ENT191 #otolaryngology #artificialintelligence #deeplearning
To view or add a comment, sign in
-
Big news in AI and healthcare: DeepSeek has officially launched its latest large language model, DeepSeek-R1, and it’s set to redefine digital pathology. This powerful AI model enhances diagnostic accuracy, enables personalized treatment strategies, and accelerates drug discovery through innovative approaches like virtual clinical trials. By integrating whole-slide imaging, genetic data, and clinical insights, DeepSeek-R1 offers a glimpse into the future of precision medicine. However, with such transformative potential comes the need for careful consideration of ethical implications, data security, and equitable access. Stay tuned—we’ll be releasing an in-depth blog article later today (once our board gives the green light) that dives deeper into the opportunities and challenges of this groundbreaking technology. The future of pathology is evolving rapidly. Let’s navigate it thoughtfully.
To view or add a comment, sign in
-
Help prepare your lab for the future of pathology with HALO AP, which offers the freedom to implement the AI algorithms that meet your needs. By enabling seamless integration of powerful tools like HALO Clinical AI as well as third-party AI, HALO AP empowers pathologists to enhance diagnostic precision and streamline workflows. Whether you're integrating new AI algorithms or optimizing your current processes, HALO AP ensures that your lab is ready to meet the challenges of tomorrow’s pathology. Read our recent blog post to learn more about HALO AP as an AI orchestration platform for digital pathology: https://lnkd.in/gScJPpE6 #DigitalPathology #AImicroscopy #TissueAnalysis #HALOap #IndicaLabs
To view or add a comment, sign in
-
-
Looking for an enterprise #DigitalPathology platform that will provide your lab with the freedom of choice to select any AI algorithm that meets your needs? Then learn more about HALO AP in #IndicaLabs’ recent blog post!
Help prepare your lab for the future of pathology with HALO AP, which offers the freedom to implement the AI algorithms that meet your needs. By enabling seamless integration of powerful tools like HALO Clinical AI as well as third-party AI, HALO AP empowers pathologists to enhance diagnostic precision and streamline workflows. Whether you're integrating new AI algorithms or optimizing your current processes, HALO AP ensures that your lab is ready to meet the challenges of tomorrow’s pathology. Read our recent blog post to learn more about HALO AP as an AI orchestration platform for digital pathology: https://lnkd.in/gScJPpE6 #DigitalPathology #AImicroscopy #TissueAnalysis #HALOap #IndicaLabs
To view or add a comment, sign in
-